ORIGINAL RESEARCH article

Front. Immunol.

Sec. Systems Immunology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1571795

This article is part of the Research TopicAdvancements in Understanding and Managing Preeclampsia: Exploring Molecular Mechanisms, Biomarkers, and Clinical ImplicationsView all 7 articles

Prediction and immune landscape study of potentially key autophagyrelated biomarkers in preeclampsia with gestational diabetes mellitus

Provisionally accepted
Qin  WangQin Wang1Xiaoqi  LiXiaoqi Li1,2Wen  YeWen Ye3Lin  LinLin Lin4Kejun  YeKejun Ye4Mengjia  PengMengjia Peng4*
  • 1Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan Province, China
  • 2Xinjiang Medical University, Ürümqi, Xinjiang Uyghur Region, China
  • 3Second Affiliated Hospital, Xinjiang Medical University, Urumqi, China
  • 4Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

Gestational diabetes mellitus and preeclampsia are prevalent pregnancy complications that threaten maternal and infant health and impose a substantial socioeconomic burden. Although several interventions have been implemented, shortcomings in individualised treatment and other limiting factors require urgent in-depth research. This study aimed to examine alterations in autophagy-related gene expression in preeclampsia combined with gestational diabetes mellitus. Through bioinformatics analyses, such as gene expression profiling, weighted gene co-expression network analysis, gene ontology and KEGG enrichment analyses, machine learning modelling, immune infiltration analyses, and single-cell analyses, we identified differentially expressed autophagy-related genes linked to preeclampsia with gestational diabetes mellitus. The expression levels of the four key genes in placental samples were validated using reverse transcription quantitative polymerase chain reaction. Our findings identified potential biomarkers and mechanisms of preeclampsia with gestational diabetes mellitus, supported by single-cell analysis, thus enhancing our understanding of their molecular mechanisms. This study details the molecular mechanisms between gestational diabetes mellitus and preeclampsia, identifies potential biomarkers and therapeutic targets, and provides a valuable reference for future research and clinical applications.

Keywords: Preeclampsia, gestational diabetes mellitus, Autophagy, Gene Expression Omnibus, Single-cell RNA

Received: 06 Feb 2025; Accepted: 14 Jun 2025.

Copyright: © 2025 Wang, Li, Ye, Lin, Ye and Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mengjia Peng, Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.